Moderna Recursion: Which Cutting-Edge Path Is Best in 2026
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Explore Ways to Fix Major Budgeting Mistakes by recalibrating spending, updating goals, and setting up durable budget processes.
17,830 articlesTwo biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
When spacex officially joined nasdaq-100, investors expected a jump in demand. Instead, the stock price moved lower a...
Trump's remarks about controlling the Strait of Hormuz sent risk-off waves through crypto markets, with Bitcoin hover...
Archer Aviation stock just slipped below the $5 mark, prompting a re-evaluation of its long-term potential. This arti...
Ripple has spent close to $3 billion on acquisitions since 2023 to build out institutional rails. The moves aim to em...
A dramatic run in Celcuity shares drew attention from traders and long-term investors alike. This article explains th...
Bitcoin's perpetual funding rates have flipped negative across top derivatives venues, suggesting shorts lead the mar...
On Mar. 5, oil surged and AI export worries weighed on tech names, sending the S&P 500, Nasdaq, and Dow lower. This a...
AeroVironment shares extended a slide after the Space Force signaled a SCAR recompete and a stop-work order. We analy...
The Trade Desk slid again amid reports of agency cautions and analyst downgrades. This piece explains the drivers, wh...
A groundbreaking 2026 risk study places hail risk homes with exposure on a footing with major hurricane threats, prom...
Nvidia unveiled a large stake in Iren to support a 5GW global AI factory plan, sending Iren’s stock higher even as th...